Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about EDIT

Recent news which mentions EDIT

< Previous 1 2 3 4 5 6 7 8 Next >
Editas Medicine, inc (EDIT) Q2 2021 Earnings Call Transcript
Tickers EDIT
Tags Market News EDIT
From Motley Fool
3 Reasons Caribou Biosciences Could Be the Best Gene-Editing Stock for Your Portfolio
Tickers CRBU CRSP EDIT NTLA
Tags VERV EDIT CRBU
From Motley Fool
Crispr Therapeutics Represents the Best of Emerging Biotechnology
Tickers CRSP EDIT NTLA
Tags Hot Stocks EDIT NASDAQ:CRSP,NASDAQ:NTLA,NASDAQ:EDIT
From InvestorPlace
The Top 2 Stocks to Buy to Play the Emerging Exoskeleton Megatrend
Tickers EDIT LAZR RBLX RWLK
Tags Market News LAZR TSLA
From InvestorPlace
5 Mid-Cap Healthcare Stocks You'll Want on Your Radar for the 2nd Half of 2021
Tickers EDIT IGMS IONS XNCR
Tags XNCR EDIT IONS
From Motley Fool
7 Best ETFs to Buy That Will Make Your World a Better Place
Tickers AMZN ARKK ARWR BABA
Tags Market News DFNV TDOC
From InvestorPlace
Editas Stock Isn’t Worth Buying This Early Into Treatment Development
Tickers EDIT
Tags Hot Stocks EDIT Market News
From InvestorPlace
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
Tickers BEAM CRSP EDIT NTLA
Tags Market News BEAM CRSP
From Motley Fool
After Game-Changing Clinical Trial Results, These 2 Cathie Wood Stocks Are Exploding
Tickers EDIT NTLA
Tags NTLA Market News EDIT
From Motley Fool
WHO Issues Framework For Governance For Gene Editing Technologies
Tickers BEAM CRSP EDIT NTLA
Tags General Government Briefs
From Benzinga
The Top 3 Gene Editing Stocks to Own for the Next Decade
Tickers AGN CRSP EDIT NTLA
Tags EDIT Stocks to Buy CRSP
From InvestorPlace
Is It Too Late to Buy Intellia Therapeutics?
Tickers BEAM EDIT NTLA REGN
Tags NTLA Market News BEAM
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.